| Title |
Breast-Conservative Surgery With and Without Radiotherapy in Patients Aged 55–75 Years With Early-Stage Breast Cancer: A Prospective, Randomized, Multicenter Trial Analysis After 108 Months of Median Follow-up
|
|---|---|
| Published in |
Annals of Surgical Oncology, October 2013
|
| DOI | 10.1245/s10434-013-3233-x |
| Pubmed ID | |
| Authors |
C. Tinterri, W. Gatzemeier, A. Costa, M. A. Gentilini, V. Zanini, L. Regolo, C. Pedrazzoli, E. Rondini, C. Amanti, G. Gentile, M. Taffurelli, P. Fenaroli, C. Tondini, G. Sacchetto, P. Sismondi, R. Murgo, M. Orlandi, E. Cianchetti, C. Andreoli |
| Abstract |
Breast-conserving therapy (BCT), including postoperative whole breast irradiation (WBI), is generally accepted as the treatment of choice for most patients with early-stage breast cancer. The question whether WBI is mandatory in all patients remains one of the most controversial issues in BCT. To answer this question, a randomized, prospective, multicentre study was launched in January 2001. Primary endpoints of the study were to assess the cumulative incidence of in-breast-recurrences (IBR) and overall survival (OAS) after conservative surgery (BCS) with or without WBI. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 29% |
| Netherlands | 2 | 29% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 86% |
| Scientists | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 62 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 18% |
| Student > Master | 8 | 13% |
| Student > Bachelor | 5 | 8% |
| Other | 5 | 8% |
| Student > Ph. D. Student | 4 | 6% |
| Other | 10 | 16% |
| Unknown | 19 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 50% |
| Biochemistry, Genetics and Molecular Biology | 4 | 6% |
| Nursing and Health Professions | 3 | 5% |
| Business, Management and Accounting | 1 | 2% |
| Computer Science | 1 | 2% |
| Other | 3 | 5% |
| Unknown | 19 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2013.
All research outputs
#8,046,138
of 25,760,414 outputs
Outputs from Annals of Surgical Oncology
#2,802
of 7,397 outputs
Outputs of similar age
#68,191
of 221,004 outputs
Outputs of similar age from Annals of Surgical Oncology
#15
of 73 outputs
Altmetric has tracked 25,760,414 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 7,397 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,004 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.